Developing New Medicines to Fight HPV Infection
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
['FUNDING_R01'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-11078681
This research looks for new medicines that can stop the human papillomavirus (HPV) from causing cancer.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-11078681 on ClinicalTrials.gov |
What this research studies
High-risk human papillomavirus (HPV) types are linked to many cancers, including those of the cervix, anus, and throat. A specific HPV protein, called E6, is crucial for the virus to cause these cancers. Our scientists are working to create tiny molecules that can attach to the E6 protein and prevent it from doing its job. We use advanced computer modeling and lab tests to design and improve these potential new medicines. The aim is to develop highly effective treatments that can stop HPV-related cancer development.
Who could benefit from this research
Good fit: This foundational research is aimed at eventually helping patients who have high-risk HPV infections or HPV-associated cancers.
Not a fit: Patients whose conditions are not related to high-risk HPV infection would not directly benefit from this specific treatment strategy.
Why it matters
Potential benefit: If successful, this work could lead to new medications that directly target and stop HPV, potentially preventing or treating HPV-associated cancers.
How similar studies have performed: Initial lab findings have shown promise with similar small molecules effectively targeting the E6 protein.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ANDROPHY, ELLIOT J. — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: ANDROPHY, ELLIOT J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anal Cancer, Anus Cancer